New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Warby Parker Inc.
WRBY
Shape
US Flag

NYSE

2B

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

2B

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

15.51USD
Shape0.47 ( 3.13%)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

-30%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

14%

Quote Panel

Shape
Updated October 3, 2024
1W -3.12 % 1M 12.70 % 3M -1.21 % 1Y 16.68 %

Key Metrics

Shape
  • Market Cap

    1.86B


  • Shares Outstanding

    119.84M


  • Share in Float

    104.20M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    15.51


  • Average Volume

    1.60M


  • Beta

    1.813


  • Range

    9.83-17.95


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.warbyparker.com


  • Sector

    Healthcare


Fundamentals

Shape

110.93x

P/E Ratio

2.56x

P/S Ratio

5.60x

P/B Ratio

0.6

Debt/Equity

-6.4%

Net Margin

$-0.4

EPS

How WRBY compares to sector?

P/E Ratio

Relative Strength

Shape

WRBY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$859M

Shape357%

2025-Revenue

$0.08

Shape248%

2025-EPS

$80M

Shape-3813%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

JMP Securities

upgrade

Previous: Not converted

2024-08-22

Now: Outperform

Evercore ISI

upgrade

Previous: Hold

2023-10-03

Now: Outperform

BTIG

initialise

Previous: Not converted

2023-02-07

Now: Neutral

Wolfe Research

initialise

Previous: Not converted

2022-12-15

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-67%

0.01
vs 0.03

Q4.22

arrow
arrow

N/A

-0.17
vs -0.08

Q1.23

arrow
arrow

+120%

0.06
vs -0.30

Q2.23

arrow
arrow

+500%

0.04
vs -0.01

Q3.23

arrow
arrow

N/A

0.01
vs 0.01

Q4.23

arrow
arrow

N/A

-0.01
vs -0.17

Q1.24

arrow
arrow

+33%

0.08
vs 0.06

Q2.24

arrow
arrow

+50%

0.06
vs 0.04

Q3.24

arrow
arrow

+423%

0.05
vs 0.01

Q4.24

arrow
arrow

+339%

0.02
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+8%

148.8M  vs 137.4M

Q4.22

arrow
arrow

+10%

146.5M  vs 132.9M

Q1.23

arrow
arrow

+12%

172M  vs 153.2M

Q2.23

arrow
arrow

+11%

166.1M  vs 149.6M

Q3.23

arrow
arrow

+14%

169.8M  vs 148.8M

Q4.23

arrow
arrow

+10%

161.9M  vs 146.5M

Q1.24

arrow
arrow

+16%

200M  vs 172M

Q2.24

arrow
arrow

+13%

188.2M  vs 166.1M

Q3.24

arrow
arrow

+12%

189.9M  vs 169.8M

Q4.24

arrow
arrow

+13%

183M  vs 161.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.11

Q4.22

arrow
arrow

-7%

-0.07
vs -0.08

Q1.23

arrow
arrow

-4%

-0.04
vs -0.07

Q2.23

arrow
arrow

-5%

-0.05
vs -0.04

Q3.23

arrow
arrow

-6%

-0.06
vs -0.05

Q4.23

arrow
arrow

-6%

-0.06
vs -0.06

Q1.24

arrow
arrow

-1%

-0.01
vs -0.06

Q2.24

arrow
arrow

-2%

-0.02
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

160

160
vs 174

-8%

Q4.22

arrow
arrow

177

177
vs 160

11%

Q1.23

arrow
arrow

165

165
vs 177

-7%

Q2.23

arrow
arrow

172

172
vs 165

4%

Q3.23

arrow
arrow

169

169
vs 172

-2%

Q4.23

arrow
arrow

186

186
vs 169

10%

Q1.24

arrow
arrow

180

180
vs 186

-3%

Q2.24

arrow
arrow

205

205
vs 180

14%

Earnings Growth

Latest News

WRBY

schaeffersresearch.com

9 hours ago